Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Finepoint Capital

Latest statistics and disclosures from Finepoint Capital's latest quarterly 13F-HR filing:

Top 5 stock holdings are LBRDK, SWTX, ASND, ARVN, RVMD, and represent 53.28% of Finepoint Capital's stock portfolio.
Added to shares of these 10 stocks: LBRDK (+$108M), ARGX (+$20M), EYPT (+$14M), Dish Network Corporation (+$14M), RVMD (+$8.1M), TVTX (+$5.8M), ACAD (+$5.2M), RLAY (+$5.1M), ASND, SWTX.
Started 5 new stock positions in ARGX, EYPT, LBRDK, Dish Network Corporation, MNYWW.
Reduced shares in these 10 stocks: , CYTK (-$14M), CERE (-$12M), MORF (-$7.5M), Ares Acquisition Cl A -cw27, Bridgetown Holdings, Churchill Capital Corp Vi, Ross Acquisition Corp Ii, Churchill Capital Corp V A, Home Plate Acquisition Cl A.
Sold out of its positions in FOLD, CERE, Churchill Capital Corp Vi, Churchill Capital Corp V A, Home Plate Acquisition Cl A, MORF, Bridgetown Holdings, Ares Acquisition Cl A -cw27, Ross Acquisition Corp Ii.
Finepoint Capital was a net buyer of stock by $138M.
Finepoint Capital has $390M in assets under management (AUM), dropping by 94.20%.
Central Index Key (CIK): 0001608126

Tip: Access up to 7 years of quarterly data

Positions held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Finepoint Capital

Finepoint Capital holds 26 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Liberty Broadband Corp Com Ser C (LBRDK)	27.7	$108M	NEW	1.9M	57.23	View chart
Springworks Therapeutics (SWTX)	7.5	$29M	+6%	593k	49.22	View chart
Ascendis Pharma A/s Sponsored Adr (ASND)	6.8	$27M	+7%	176k	151.17	View chart
Arvinas Ord (ARVN)	5.7	$22M	+6%	539k	41.28	View chart
Revolution Medicines (RVMD)	5.6	$22M	+58%	677k	32.23	View chart
Sarepta Therapeutics (SRPT)	5.3	$21M	+9%	159k	129.46	View chart
Argenx Se Sponsored Adr (ARGX)	5.0	$20M	NEW	50k	393.72	View chart
Moonlake Immunotherapeutics Class A Ord (MLTX)	4.6	$18M	+8%	361k	50.23	View chart
Cytokinetics Com New (CYTK)	4.3	$17M	-44%	238k	70.11	View chart
Galapagos Nv Spon Adr (GLPG)	4.2	$16M	+9%	504k	32.20	View chart
ACADIA Pharmaceuticals (ACAD)	4.0	$16M	+51%	841k	18.49	View chart
Eyepoint Pharmaceuticals Com New (EYPT)	3.5	$14M	NEW	657k	20.67	View chart
Dish Network Corporation Note 12/1 (Principal)	3.4	$14M	NEW	18M	0.73	View chart
Solid Biosciences Com New (SLDB)	3.3	$13M		961k	13.32	View chart
Travere Therapeutics (TVTX)	3.3	$13M	+84%	1.6M	7.71	View chart
Relay Therapeutics (RLAY)	3.2	$12M	+71%	1.5M	8.30	View chart
Prothena Corp SHS (PRTA)	2.6	$10M	+15%	402k	24.77	View chart
Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW)	0.0	$175k		548k	0.32	View chart
Moneyhero *w Exp 09/13/202 (MNYWW)	0.0	$109k	NEW	895k	0.12	View chart
Calidi Biotherapeutics Com New (CLDI)	0.0	$71k		125k	0.56	View chart
Concord Acquisition Corp Ii *w Exp 99/99/999 (CNDA.WS)	0.0	$45k		408k	0.11	View chart
Compass Digital Acquisition Corp *w Exp 09/29/202 (CDAQW)	0.0	$42k		460k	0.09	View chart
Calidi Biotherapeutics *w Exp 03/14/202 (CLDI.WS)	0.0	$34k		655k	0.05	View chart
Swiftmerge Acquisition Corp *w Exp 12/13/202 (IVCPW)	0.0	$27k		490k	0.06	View chart
Ys Biopharma *w Exp 03/15/202 (YSBPW)	0.0	$25k		490k	0.05	View chart
Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW)	0.0	$8.2k		735k	0.01	View chart

Past Filings by Finepoint Capital

SEC 13F filings are viewable for Finepoint Capital going back to 2014

Finepoint Capital 2024 Q1 filed May 14, 2024
Finepoint Capital 2023 Q3 filed Nov. 13, 2023
Finepoint Capital 2023 Q2 filed Aug. 11, 2023
Finepoint Capital 2023 Q1 filed May 12, 2023
Finepoint Capital 2022 Q4 filed Feb. 13, 2023
Finepoint Capital 2022 Q3 filed Nov. 10, 2022
Finepoint Capital 2022 Q2 filed Aug. 12, 2022
Finepoint Capital 2022 Q1 filed May 13, 2022
Finepoint Capital 2021 Q4 filed Feb. 11, 2022
Finepoint Capital 2021 Q3 filed Nov. 12, 2021
Finepoint Capital 2021 Q2 filed Aug. 13, 2021
Finepoint Capital 2021 Q1 filed May 14, 2021
Finepoint Capital 2020 Q4 filed Feb. 12, 2021
Finepoint Capital 2020 Q3 filed Nov. 13, 2020
Finepoint Capital 2020 Q2 filed Aug. 13, 2020
Finepoint Capital 2020 Q1 filed May 13, 2020

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z